1.      国家重点研发计划：全外显子测序联合microRNA聚类分析对子宫内膜异位症恶变机制的研究，已结题。

2.      国家科技部对外合作项目：利用生物靶向技术治疗妊娠期高血压的合作研究，已结题。

3.      国家科技部对外合作项目：抗女性生殖系统恶性肿瘤树突状细胞疫苗技术的合作研究，已结题。

4.      国家高技术研究发展计划（863计划）：三种妇科恶性肿瘤蛋白分子分型特征的研究与蛋白分型诊断芯片的研发，已结题。

5.      首都卫生发展科研专项：妇科盆腔手术后下肢深静脉血栓形成机械与药物预防的多中心随机对照研究，已结题。

6.      国家科技部对外合作项目：子痫及子痫前期孕妇血清蛋白功能变异与免疫治疗，已结题。

7.      国家自然科学基金面上项目：RBP4蛋白对子痫前期胎盘滋养细胞生物学功能的调控及分子机制，已结题。

8.      首都特色临床应用研究：腹腔镜疼痛定位在慢性盆腔痛诊断和治疗中的应用，已结题。

9.      卫生和计划生育委员会公益性行业科研专项基金：适合农村地区的宫颈癌筛查技术及示范研究，已结题。

10.    国家自然科学基金青年科学基金项目：TTR通过LAMP-1参与内皮细胞凋亡在子痫前期螺旋动脉血管重铸的作用研究，已结题。

11.    国家自然科学基金：卵巢癌细胞激励的脐血树突状细胞诱发抗肿瘤免疫及机制，已结题。

[1]   Deng Yupeng, Lou Tong, Kong Lili, Liu Chongdong. Prohibitin2/PHB2,Transcriptionally Regulated by GABPA, Inhibits Cell Growth viaPRKN/Parkin-dependent Mitophagy in Endometriosis [published online ahead ofprint, 2023 Aug 16]. Reprod Sci. 2023;10.1007/s43032-023-01316-7.

[2]    Feng Ying, Xiao Meizhu, Cao Guangming, Liu Hao, LiYanfang, Wang Shuzhen, Zijtveld Stan, Delvoux Bert, Xanthoulea Sofia, RomanoAndrea, Liu Chongdong, Zhang Zhenyu.(2022). Human monocytes differentiate intotumor-associated macrophages upon SKOV3 cells coculture and/or lysophosphatidicacid stimulation. J Inflamm (Lond), 19(1), 11.

[3]    Yang Changmei, Wang Tianxiang, Zhao Yujiao, MengXianbin, Ding Wenxi, Wang Qingtao, Liu Chongdong, Deng Haiteng.(2022).Flavonoid 4,4'-dimethoxychalcone induced ferroptosis in cancer cells bysynergistically activating Keap1/Nrf2/HMOX1 pathway and inhibiting FECH. FreeRadic Biol Med, 188(undefined), 14-23.

[4]    Feng Ying, Wang Zhixiang, Cui Ran, Xiao Meizhu, GaoHuiqiao, Bai Huimin., Delvoux Bert, Zhang Zhen, Dekker Andre, Romano Andrea,Wang Shuzhen, Traverso Alberto, Liu Chongdong, Zhang Zhenyu.(2022). Clinicalanalysis and artificial intelligence survival prediction of serous ovariancancer based on preoperative circulating leukocytes. J Ovarian Res, 15(1), 64.

[5]    Gao Jie, Luo Mei, Zhao Shuo, Wang Hailing, Li Xuan,Xu Pili, Ma Wei, Liu Chongdong.(2022). Effect of PM2.5 exposure on gestationalhypertension, fetal size in preeclampsia-like rats. Environ Sci Pollut Res Int,29(30), 45808-45820.

[6]    Lou Tong, Liu Chongdong, Qu Hong, Zhang Zhiqiang,Wang Shuzhen, Zhuang Huiyu.(2022). FOXA1 can be modulated by HDAC3 in theprogression of epithelial ovarian carcinoma. J Transl Med, 20(1), 19.

[7]    Zhang Jing, Chen Xin-Wei, Shu Li-Sha, LiuChong-Dong.(2022). The correlation and role analysis of SLC30A1 and SLC30A10 incervical carcinoma. J Cancer, 13(3), 1031-1047.

[8]    Han Y, Liu C . Clinicopathological characteristicsand prognosis of uterine serous carcinoma: A SEER program analysis of 1016cases[J]. Journal of Obstetrics and Gynaecology Research, 2021(1).

[9]    Mu BoRan, Zhang ZhiQiang, Liu Chongdong, ZhangKunning, Li ShuHong, Leng JinHua, Li MengHui. Long term follow-up of inguinalendometriosis. BMC Womens Health. 2021;21(1):90.

[10]  Liu H , Wang W, Liu C. Increased expression of IFNγin preeclampsia impairs human trophoblast invasion via a SOCS1/JAK/STAT1feedback loop[J]. Experimental and Therapeutic Medicine, 2020, 21(2).

[11]  Feng Y , Xiao M , Zhang Z , et al. Potentialinteraction between lysophosphatidic acid and tumor-associated macrophages inovarian carcinoma[J]. Journal of Inflammation, 2020, 17(1).

[12]  Tong L, Liang H, Zhuang H, Liu C, Zhang Z. TheRelationship between HDAC3 and Malignant Tumors: A Mini Review. Crit RevEukaryot Gene Expr. 2020;30(3):279-284.

[13]  Lu Qi,Qu Hong,Lou Tong et al. CK19 Promotes OvarianCancer Development by Impacting on Wnt/β-Catenin Pathway.[J] .Onco TargetsTher, 2020, 13: 2421-2431.

[14]  Feng Ying,Wang Qiushi,Shi Can et al. Does CircularRNA Exert Significant Effects in Ovarian Cancer?[J] .Crit. Rev. Eukaryot. GeneExpr., 2019, 29: 161-170.

[15]  Li Hongxia,Cao Guangming,Lou Tong et al.Construction and function of a fusion protein consisting of a single‑chainvariable fragment and RBP4.[J] .Mol Med Rep, 2019, 20: 671-677.

[16]  Lou Tong, Zhuang Huiyu, Liu Chongdong, ZhangZhenyu. HDAC3 positively regulates HE4 expression to promote ovarian carcinomaprogression. Arch Biochem Biophys. 2019;675:108044.

[17]  Lu Qi, Zhang Zhiqiang, Xiao Meizhu, Liu Chongdong,Zhang Zhenyu.The Surgical Morbidity And Oncological Outcome Of TotalLaparoscopic Radical Trachelectomy Versus Total Laparoscopic RadicalHysterectomy For Early Stage Cervical Cancer: A Retrospective Study With11-Year Follow-Up. Onco Targets Ther. 2019;12:7941-7947. Published 2019 Sep 26.

[18]  Li Hongxia,Cao Guangming,Zhang Nawei et al. RBP4regulates trophoblastic cell proliferation and invasion via the PI3K/AKTsignaling pathway.[J] .Mol Med Rep, 2018, 18: 2873-2879.

[19]  Xiao Meizhu, Feng Ying, Liu Chongdong, ZhangZhenyu. Prognostic values of long noncoding RNA PVT1 in various carcinomas: Anupdated systematic review and meta-analysis. Cell Prolif.2018;51(6):e12519.  Yu Wentao, Cui Ran,Qu Hong, Liu Chongdong, Deng Haiteng, Zhang Zhenyu. Expression and prognosticvalue of CLIC1 in epithelial ovarian cancer. Exp Ther Med.2018;15(6):4943-4949.

[20]  Xiao Meizhu, Feng Ying, Cao Guangming, LiuChongdong, Zhang Zhenyu. A novel MtHSP70-FPR1 fusion protein enhances cytotoxicT lymphocyte responses to cervical cancer cells by activating humanmonocyte-derived dendritic cells via the p38 MAPK signaling pathway. BiochemBiophys Res Commun. 2018;503(3):2108-2116.

[21]  Xiao Meizhu, Feng Ying, Liu Chongdong, Zhang Zhenyu.Prognostic values of long noncoding RNA PVT1 in various carcinomas: An updatedsystematic review and meta-analysis. Cell Prolif. 2018;51(6):e12519.